combination effects of recombinant human interleukin-1 alpha with ceftazidime , moxalactam , gentamicin , enoxacin , amphotericin b , miconazole , or an immunoglobulin preparation were evaluated in systemic infections with pseudomonas aeruginosa , klebsiella pneumoniae , and candida albicans in normal mice and systemic infection with p. aeruginosa in mice with leukopenia induced by preadministration of cyclophosphamide .
C0007559
ceftazidime
C0243026
systemic infections